Benzoyl peroxide

Identification

Name
Benzoyl peroxide
Accession Number
DB09096
Type
Small Molecule
Groups
Approved
Description

Benzoyl peroxide (BPO) is an organic compound in the peroxide family. It consists of two benzoyl groups bridged by a peroxide link. It is one of the most important organic peroxides in terms of applications. In medicine, benzoyl peroxide is used as a topical treatment for acne, either in combination with antibiotics or as a single agent. These products are available over-the-counter or by prescription in gels, creams or liquids at concentrations of 2.5%, 5% or 10%. Benzoyl peroxide is also used for bleaching flour or hair, teeth whitening, for cross-linking polyester resins, and many other chemical uses. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.

Structure
Thumb
Synonyms
  • Benzoyl benzenecarboperoxoate
  • Bepio
External IDs
NSC-671 / NSC-675
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
10 Benzagel Gel - 10%Gel10 %TopicalDermik Laboratories1998-12-012005-10-05Canada
Acetoxyl 10 GelGel10 %TopicalValeo Pharma Corp.1978-12-312006-07-31Canada
Acetoxyl 20acne GelGel20 %TopicalStiefel Laboratories, Inc.1978-12-311998-07-09Canada
BenoxylLotion20 %TopicalGlaxosmithkline Inc1970-12-312012-12-10Canada
BenoxylLotion10 %TopicalGlaxosmithkline Inc1976-12-312011-12-22Canada
Benoxyl 10% WashLiquid10 %TopicalStiefel Laboratories, Inc.1980-12-311998-07-09Canada
Benzac Ac Gel 10%Gel10 %TopicalGalderma1991-12-312016-08-04Canada
Benzac W Wash Gel 10%Gel10 %TopicalGalderma1991-12-31Not applicableCanada
Benzac W10 Gel 10% USPGel10 %TopicalGalderma1980-12-312005-08-04Canada
Benzagel 10 Gel 10%Gel10 %TopicalRhone Poulenc Rorer1993-12-311999-08-12Canada
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
2.5 Benzagel 2.5%Gel2.5 %TopicalRhone Poulenc Rorer1993-12-311997-08-13Canada
2.5 Benzagel 2.5% Acne GelGel2.5 %TopicalNovartis1996-09-291999-07-21Canada
2.5 Benzagel Acne Lotion 2.5%Lotion2.5 %TopicalRhone Poulenc Rorer1993-12-311997-08-13Canada
2.5 Benzagel Acne Lotion 2.5%Lotion2.5 %TopicalNovartis1996-09-301999-07-21Canada
3 Step Acne System Well at WalgreensKitWalgreens2014-07-15Not applicableUs
5 Benzagel Liquid Acne Soap 5%Liquid5 %TopicalRhone Poulenc Rorer1993-12-311996-09-09Canada
5 Benzagel Lotion 5%Lotion5 %TopicalRhone Poulenc Rorer1993-12-311997-08-13Canada
5% BP Face and Body WashLiquid50 mg/mLTopicalCos Medical Technologies2015-11-04Not applicableUs
AB Skincare Acne Spot TreatmentCream28.3 g/100gTopicalNorris Ltd2017-10-09Not applicableUs
Acetoxyl 2.5 GelGel2.5 %TopicalValeo Pharma Corp.1978-12-312011-08-02Canada
Unapproved/Other Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
BenzEFoamAerosol, foam5.3 g/100gTopicalOnset Dermatologics, LLC2009-09-18Not applicableUs
BenzEFoam UltraAerosol, foam9.8 g/100gTopicalOnset Dermatologics, LLC2011-03-04Not applicableUs
BenzePrO Creamy WashSoap7 g/100gTopicalPru Gen Pharmaceuticals2015-07-01Not applicableUs
Benzoyl PeroxideLiquid2.5 g/100gTopicalPerrigo New York Inc.2008-02-082017-07-27Us
Benzoyl PeroxideLiquid10 g/100gTopicalPerrigo New York Inc.2008-05-192017-01-18Us
Benzoyl Peroxide aqueous baseGel2.5 g/100gTopicalPerrigo New York Inc.2008-09-242017-01-18Us
Benzoyl peroxide emollientAerosol, foam5.3 g/100gTopicalMetacon Labs2011-04-012016-03-31Us
Benzoyl peroxide short contactAerosol, foam9.8 g/100gTopicalMetacon Labs2011-04-012017-02-28Us
BPO 3 FoamingCloth3.2 g/100gTopicalAcella Pharmaceuticals, LLC2010-08-182017-08-17Us
BPO 6 FoamingCloth3.2 g/100gTopicalAcella Pharmaceuticals, LLC2010-08-18Not applicableUs
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
AcanyaBenzoyl peroxide (25 mg/g) + Clindamycin phosphate (10 mg/g)GelTopicalValent Pharmaceuticals North America2010-07-26Not applicableUs
Acne Clearning Treatment FaceBenzoyl peroxide (.006 mg/.024mg) + Salicylic acid (.0048 mg/.024mg) + Sulfur (.012 mg/.024mg)LiquidTopicalCare Pluss Pharma S.A. De C.V.2012-08-06Not applicableUs
Acne Treatment SystemBenzoyl peroxide (5 %) + Salicylic acid (2 %)Kit; Liquid; LotionTopicalVivier Canada Incorporated2013-11-15Not applicableCanada
Acne Treatment SystemBenzoyl peroxide + Salicylic acidKitVivier Pharma2017-07-19Not applicableUs
Active Anti-acne Treatment KitBenzoyl peroxide (2.5 %) + Benzoyl peroxide (2.5 %)Kit; LotionTopicalFruit Of The Earth, Inc.2015-12-10Not applicableCanada
Active Anti-acne Treatment KitBenzoyl peroxide (2.5 %) + Benzoyl peroxide (2.5 %)Kit; LotionTopicalFruit Of The Earth, Inc.2015-12-10Not applicableCanada
Adapalene and Benzoyl PeroxideBenzoyl peroxide (25 mg/g) + Adapalene (1 mg/g)GelTopicalPrasco, Laboratories2017-08-03Not applicableUs
Adapalene and Benzoyl PeroxideBenzoyl peroxide (25 mg/g) + Adapalene (1 mg/g)GelTopicalActavis Pharma Company2017-07-27Not applicableUs
Advantage Acne Control KitBenzoyl peroxide (2.5 %) + Benzoyl peroxide (5 %)Gel; Kit; LotionTopicalJohnson & Johnson2017-01-30Not applicableCanada
Advantage Acne Control KitBenzoyl peroxide (2.5 %) + Benzoyl peroxide (5 %)Gel; Kit; LotionTopicalJohnson & Johnson2017-01-30Not applicableCanada
Categories
UNII
W9WZN9A0GM
CAS number
94-36-0
Weight
Average: 242.2268
Monoisotopic: 242.057908808
Chemical Formula
C14H10O4
InChI Key
OMPJBNCRMGITSC-UHFFFAOYSA-N
InChI
InChI=1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H
IUPAC Name
benzoyl benzenecarboperoxoate
SMILES
O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1

Pharmacology

Indication

Benzoyl peroxide is indicated for the treatment of mild to moderate acne vulgaris and rosacea. Combined with other agents, it may be used in the treatment of more severe acne.

Structured Indications
Pharmacodynamics

Benzoyl peroxide acts as an antibacterial, irritant, keratolytic, comedolytic, and anti-inflammatory agent when applied topically to the human epithelium.

Mechanism of action

Benzoyl peroxide decomposes to release oxygen after topical application. This oxygen acts as a bactericidal agent towards Proprionibacterium acnes, the bacteria present in acne vulgaris. Benzoyl peroxide also increases the turnover rate of epithelial cells, thereby peeling the skin and promoting the resolution of comedones.

Absorption

Benzoyl peroxide is absorbed percutaneously into the dermal layer of the epithelium. It is then metabolized to benzoic acid which can be absorbed systemically. There is no systemic absorption of benzoyl peroxide itself.

Volume of distribution

Benzoyl peroxide is not absorbed or distributed systemically after topical application.

Protein binding

Benzoyl peroxide does not undergo protein binding as it is does not enter systemic circulation after topical application.

Metabolism

Benzoyl peroxide undergoes metabolism by keratinocytes in the epidermis. Initially, the peroxide bond is cleaved to form benzoyloxyl radicals. It is thought this reaction may be copper-catalyzed. The benzoyloxyl radicals may then fragment to form carbon dioxide and a phenyl radical. Alternatively, the radicals may gain a hydrogen atom from biomolecules forming the more stable and primary metabolite, benzoic acid.

Route of elimination

Renal clearance of the primary metabolite, benzoic acid, is rapid and thought to preclude hepatic conjugation.

Half life

Benzoyl peroxide is not absorbed into systemic circulation after topical application. Further studies are needed on its half life within the epithelium.

Clearance

Benzoyl peroxide is not absorbed into systemic circulation after topical application. Its primary metabolite, benzoic acid, is cleared rapidly via renal excretion and hepatic conjugation is thought to be bypassed.

Toxicity

There is no evidence to support carcinogenicity in humans. Benzoyl peroxide may cause contact hypersensitivity, stinging and burning sensations when applied topically. It should not be applied under occlusive dressings due to risk of sensitization. During processing and formulation, exposure to concentrations higher than 12.2 mg/cu may cause irritation to the nose and/or throat.

Affected organisms
  • Propionibacterium acnes
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
DapsoneThe risk or severity of adverse effects can be increased when Benzoyl peroxide is combined with Dapsone.Approved, Investigational
Food Interactions
Not Available

References

Synthesis Reference
  1. Zenz, C. Occupational Medicine - Principles and Practical Applications. 2nd ed. St. Louis, MO: Mosby-Yearbook Inc.; 1988: 712.
  2. Budavari, S. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc.; 1996: 187.
  3. Ashford, RD. Ashford's Dictionary of Industrial Chemicals. London, England: Wavelength Publications Ltd.; 1994: 119.
General References
  1. Bojar RA, Cunliffe WJ, Holland KT: The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol. 1995 Feb;132(2):204-8. [PubMed:7888356]
  2. Kawashima M, Nagare T, Katsuramaki T: Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication. J Dermatol. 2017 Feb 2. doi: 10.1111/1346-8138.13741. [PubMed:28150367]
  3. Francis NA, Entwistle K, Santer M, Layton AM, Eady EA, Butler CC: The management of acne vulgaris in primary care: a cohort study of consulting and prescribing patterns using the Clinical Practice Research Datalink. Br J Dermatol. 2017 Jan;176(1):107-115. doi: 10.1111/bjd.15081. Epub 2016 Dec 27. [PubMed:27716910]
  4. Rosamilia LL: Over-the-counter treatments for acne and rosacea. Semin Cutan Med Surg. 2016 Jun;35(2):87-95. doi: 10.12788/j.sder.2016.026. [PubMed:27416314]
  5. Yeung D, Nacht S, Bucks D, Maibach HI: Benzoyl peroxide: percutaneous penetration and metabolic disposition. II. Effect of concentration. J Am Acad Dermatol. 1983 Dec;9(6):920-4. [PubMed:6643790]
  6. Nacht S, Yeung D, Beasley JN Jr, Anjo MD, Maibach HI: Benzoyl peroxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981 Jan;4(1):31-7. [PubMed:7204686]
  7. Swauger JE, Dolan PM, Zweier JL, Kuppusamy P, Kensler TW: Role of the benzoyloxyl radical in DNA damage mediated by benzoyl peroxide. Chem Res Toxicol. 1991 Mar-Apr;4(2):223-8. [PubMed:1782351]
External Links
Human Metabolome Database
HMDB32040
KEGG Drug
D03093
KEGG Compound
C19346
PubChem Compound
7187
PubChem Substance
310265023
ChemSpider
6919
ChEBI
82405
ChEMBL
CHEMBL1200370
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
Wikipedia
Benzoyl_peroxide
ATC Codes
D10AE51 — Benzoyl peroxide, combinationsD10AE01 — Benzoyl peroxide
AHFS Codes
  • 84:28.00 — Keratolytic Agents
MSDS
Download (37.4 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0RecruitingTreatmentOsteomyelitis1
1CompletedPreventionAcne Vulgaris1
1CompletedTreatmentAcne Vulgaris6
2CompletedTreatmentAcne Vulgaris1
2Enrolling by InvitationPreventionSurgical Site Infections1
3CompletedTreatmentAcne4
3CompletedTreatmentAcne Vulgaris11
3Not Yet RecruitingTreatmentAcne Vulgaris1
3Unknown StatusTreatmentAcne Vulgaris2
4Active Not RecruitingPreventionAcne Vulgaris / Atrophic Acne Scars1
4CompletedNot AvailableAcne Vulgaris1
4CompletedNot AvailableP Acnes Colonization1
4CompletedTreatmentAcne1
4CompletedTreatmentAcne Vulgaris19
4CompletedTreatmentSkin Diseases1
4Unknown StatusTreatmentAcne Vulgaris1
4Unknown StatusTreatmentTreatment of Acne Vulgaris Grade II in a Short Period of Time1
Not AvailableCompletedNot AvailableAcne1
Not AvailableCompletedNot AvailableAcne Vulgaris1
Not AvailableCompletedTreatmentAcne Vulgaris8
Not AvailableRecruitingPreventionShoulder Infection1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
CreamTopical28.3 g/100g
LiquidTopical
GelTopical5 mL/100mL
Shampoo, suspensionTopical25 mg/mL
LotionTopical100 mg/1000mL
LotionTopical50 mg/1000mL
CreamTopical10 g/100mL
LotionTopical30 mg/g
SolutionTopical5.0 %
GelTopical1 mg/g
GelTopical3.5 g/100mL
Kit; liquid; lotionTopical
CreamTopical25 mg/g
LiquidTopical4.25 g/170g
CreamTopical3.4 g/136g
LiquidTopical25 mg/mL
CreamTopical50 mg/g
LotionTopical10 mL/100mL
CreamTopical100 mg/g
Kit; lotionTopical
Liquid, extended releaseTopical44 mg/mL
Gel; kit; lotionTopical
Aerosol, foamTopical2.5 g/100g
CreamTopical5.5 g/100mL
CreamTopical.026 mg/mg
CreamTopical1.4 g/28g
LotionTopical5 g/100mL
LotionTopical20 %
SolutionTopical2.6 g/100mL
GelTopical2.6 %
GelTopical10 %
GelTopical5 %
LiquidTopical5 %
GelTopical2.5 %
Kit
Aerosol, foamTopical3.18 g/60g
Aerosol, foamTopical9.8 g/100g
SoapTopical7 g/100g
LotionTopical3 g/100mL
Aerosol, foamTopical53 mg/g
Aerosol, foamTopical98 mg/g
GelTopical100 mg/g
GelTopical50 mg/g
KitTopical
LiquidTopical10 g/100g
LiquidTopical2.5 g/100g
LiquidTopical30 mg/mL
LiquidTopical5 g/100g
LiquidTopical60 mg/mL
LiquidTopical90 mg/mL
GelTopical50 mg/1000mg
SolutionTopical2.5 %
GelTopical2.5 g/100g
GelTopical35 mg/g
Aerosol, foamTopical5.3 g/100g
CreamTopical3.29 g/56g
CreamTopical2.5 mL/100mL
GelTopical5 g/100mL
GelTopical5.0 %
EmulsionTopical42.5 mg/mL
LotionTopical40 mg/g
GelTopical55 mg/g
EmulsionTopical100 mg/g
EmulsionTopical25 mg/g
EmulsionTopical50 mg/g
EmulsionTopical52.5 mg/g
EmulsionTopical70 mg/mL
GelTopical4 mg/100mg
GelTopical8 mg/100mg
ClothTopical3.2 g/100g
SolutionTopical5 %
ClothTopical9 g/100g
LotionTopical5 mL/100mL
CreamTopical1.125 g/15g
GelTopical5.00 %
AerosolTopical2.5 %
CreamTopical5.0 %
LotionTopical5 %
LiquidTopical5.57 mg/g
GelTopical25 mg/g
LiquidTopical.006 mg/.024mg
LotionTopical
LiquidTopical3 %
CreamTopical30 mg/mL
LiquidTopical3.7 %
LotionTopical3.5 %
LiquidTopical3.5 %
CreamTopical5 %
ClothTopical
Kit; lotionTopical5 %
LotionTopical2.5 %
CreamTopical25 mg/mL
CreamTopical.8 mg/29.6mg
GelTopical61.62 mg/mL
CreamTopical4 g/100g
SoapTopical100 mg/g
CreamTopical104 mg/10g
GelTopical20 %
SolutionTopical10 mg/mL
SolutionTopical10 mg/g
SolutionTopical5 mg/mL
SolutionTopical5 mg/g
LotionTopical10 %
SolutionTopical5 g/100mL
LotionTopical2.5 g/100mL
Gel; lotionTopical2.5 %
ClothTopical2.5 %
Liquid, extended releaseTopical4.5 mg/100mL
LiquidTopical.1 mg/g
GelTopical135 mg/g
GelTopical25 mg/mL
LiquidTopical3 g/120g
LotionTopical1.5 g/60g
LotionTopical25 mg/mL
CreamTopical10 g/100g
CreamTopical4 %
GelTopical5.6 g/56g
GelTopical3 mL/60mL
LotionTopical45 mg/mL
GelTopical51.9 mg/100mL
CreamTopical10 %
CreamTopical20 %
CreamTopical2.5 %
CreamTopical5.3 g/100g
GelTopical10 g/100mL
SuspensionTopical10 g/100g
LotionTopical55 mg/mL
LotionTopical2.2 mg/40mL
CreamTopical1 g/100g
CreamTopical5 g/100mL
CreamTopical5 g/100g
GelTopical
KitTopical
PasteTopical5 %
GelTopical3.5 %
GelTopical35 mg/mL
LotionTopical35 mg/mL
CreamTopical37 mg/mL
SuspensionTopical37 mg/mL
JellyTopical2.5 %
CreamTopical2.5 mg/g
LotionTopical.05 mL/mL
LotionTopical5.0 %
GelTopical7 mg/g
SolutionTopical2.5 g/100mL
CreamTopical2.5 g/100g
LotionTopical3.0 %
LotionTopical100 mg/g
LotionTopical50 mg/g
OintmentTopical5 %
LiquidTopical100 mg/mL
LiquidTopical50 mg/mL
SwabTopical25 mg/1
StickTopical50 mg/g
CreamTopical100 mg/mL
CreamTopical50 mg/mL
ClothTopical70 mg/g
ClothTopical42.5 mg/g
CreamTopical146.7 mg/g
CreamTopical30 mg/g
CreamTopical58.7 mg/g
SoapTopical.5 g/10g
SoapTopical1 g/10g
SoapTopical11.3 g/1
SoapTopical5.65 g/1
SoapTopical10 %
SoapTopical5 %
LiquidTopical4 %
LiquidTopical10 %
Kit; lotion; solutionTopical
GelTopical10 g/100g
GelTopical5 g/100g
LotionTopical5 g/100g
SolutionTopical.063 mg/2.5mL
LotionTopical.063 mg/2.5mL
LotionTopical70 mg/mL
Gel; kitTopical
CreamTopical.06 g/g
LotionTopical7 mg/100mL
CreamTopical7 mg/100mL
GelTopical2.5 mg/100mL
CreamTopical.025 g/1000mL
CreamTopical.25 g/1000mL
GelTopical2.5 g/100mL
LotionTopical2.5 mL/100mL
GelTopical2.5 mL/100mL
LotionTopical2.5 mg/100mL
LotionTopical3 %
CreamTopical52.5 mg/mL
LiquidTopical7.5 mL/100mL
CreamTopical2.95 mL/59mL
Aerosol, foamTopical55 mg/g
Aerosol, foamTopical95 mg/g
LotionTopical2.50 %
Cream; gel; kit; lotionTopical2.5 %
GelTopical100 mg/mL
GelTopical50 mg/mL
LotionTopical100 mg/mL
LotionTopical50 mg/mL
Kit
LiquidTopical2.5 %
PasteTopical3.5 %
SwabTopical25 mg/mL
LotionTopical25 mg/g
GelTopical4 %
GelTopical8 %
GelTopical3 %
LotionTopical4 %
Gel; kit; pasteTopical
CreamTopical
LotionTopical2.5 g/100g
SoapTopical60 mg/g
SwabTopical2.75 mg/1
GelTopical8.5 mg/100g
OintmentTopical100 mg/g
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US8909305No2002-12-232022-12-23Us
US8703820No2003-03-122023-03-12Us
US7964202No2004-09-012024-09-01Us
US8071644No2007-07-182027-07-18Us
US8080537No2007-07-182027-07-18Us
US8105618No2002-12-232022-12-23Us
US8129362No2007-07-182027-07-18Us
US8445543No2007-07-122027-07-12Us
US8809305No2002-12-232022-12-23Us
US8936800No2002-12-232022-12-23Us
US8241649No2002-12-232022-12-23Us
US7820186No2005-11-232025-11-23Us
US8288434No2009-08-052029-08-05Us
US8663699No2009-06-032029-06-03Us
US8895070No2009-06-032029-06-03Us
US9078870No2009-06-032029-06-03Us
US8785420No2002-12-232022-12-23Us
US8729127No2003-03-122023-03-12Us
US9504704No2009-06-032029-06-03Us
US9561208No2009-06-032029-06-03Us
US9381179No2003-03-122023-03-12Us
US9387187No2003-03-122023-03-12Us

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)103 - 106 Budavari, S. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc.; 1996: 187.
boiling point (°C)Decomposes explosively above melting point. Does not reach boiling point.United States Department of Labor. OSHA Occupational Chemical Database. Occupational Safety and Health Administration website. https://www.osha.gov/chemicaldata/chemResult.html?RecNo=748. Accessed February 22, 2017.
water solubility<1%United States Department of Labor. OSHA Occupational Chemical Database. Occupational Safety and Health Administration website. https://www.osha.gov/chemicaldata/chemResult.html?RecNo=748. Accessed February 22, 2017.
Predicted Properties
PropertyValueSource
Water Solubility0.0294 mg/mLALOGPS
logP2.75ALOGPS
logP3.95ChemAxon
logS-3.9ALOGPS
pKa (Strongest Basic)-7.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area52.6 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity64.77 m3·mol-1ChemAxon
Polarizability24.16 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as benzoyl peroxides. These are organic compounds containing two benzoyl groups O-linked to each other via a peroxide group. Their skeleton has the general formula [C6H5C(O)]2O2.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoyl peroxides
Direct Parent
Benzoyl peroxides
Alternative Parents
Peroxybenzoic acids and derivatives / Benzoyl derivatives / Dicarboxylic acids and derivatives / Peroxycarboxylic acids and derivatives / Carboxylic acid salts / Organooxygen compounds / Organic salts / Organic oxides / Hydrocarbon derivatives
Substituents
Benzoyl peroxide / Peroxybenzoate / Benzoic acid or derivatives / Benzoyl / Dicarboxylic acid or derivatives / Peroxycarboxylic acid or derivatives / Carboxylic acid salt / Carboxylic acid derivative / Organic oxygen compound / Organic oxide
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
carbonyl compound (CHEBI:82405)

Drug created on September 16, 2015 12:04 / Updated on November 19, 2017 20:34